The pharmaceutical industry constantly seeks innovative compounds and efficient synthesis routes to develop life-saving medications. At the heart of many drug manufacturing processes are chemical intermediates – compounds that serve as building blocks for the final Active Pharmaceutical Ingredient (API). Methyl 3-Bromobutanoate (CAS 21249-59-2) stands out as a crucial intermediate, valued for its versatile reactivity and direct application in synthesizing a wide array of therapeutic agents. This article explores the significance of Methyl 3-Bromobutanoate in API synthesis and guides potential buyers on how to procure this essential chemical.

Methyl 3-Bromobutanoate, a clear, colorless liquid, possesses a molecular formula of C5H9BrO2 and a molecular weight of approximately 181.03. Its chemical structure, featuring a reactive bromine atom on the third carbon and a methyl ester group, makes it an excellent starting material or intermediate for various organic reactions, including nucleophilic substitutions and ester modifications. For API manufacturers, obtaining this intermediate with a high purity level, typically ≥98.0%, is critical to ensure the efficiency and purity of the final drug product. The ability to purchase this chemical reliably and at a reasonable price is a key consideration for production planning.

The application of Methyl 3-Bromobutanoate in API synthesis is extensive. It can be incorporated into complex molecular structures through various coupling and derivatization reactions. For instance, it might be used in the synthesis of specific anti-cancer drugs, cardiovascular agents, or central nervous system (CNS) medications. Researchers and production chemists often look for manufacturers who can guarantee consistent quality and a stable supply, ensuring that their synthesis processes are not disrupted. When considering the purchase of Methyl 3-Bromobutanoate, understanding its role within a specific synthetic pathway is paramount.

For procurement professionals and R&D scientists, identifying a dependable supplier is crucial. Manufacturers in China, such as NINGBO INNO PHARMCHEM CO.,LTD., have established themselves as key players in providing high-quality pharmaceutical intermediates like Methyl 3-Bromobutanoate. These suppliers often offer competitive pricing, especially for bulk orders, and can provide necessary documentation such as Certificates of Analysis (CoA) and Safety Data Sheets (SDS). Engaging with a manufacturer to obtain a quote is the first step towards securing this essential compound for your pharmaceutical projects.

In summary, Methyl 3-Bromobutanoate (CAS 21249-59-2) is an indispensable intermediate in the synthesis of many APIs. Its unique chemical properties lend themselves to diverse synthetic strategies. For companies aiming to purchase this compound, focusing on purity, reliability of supply, and competitive pricing from established manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. is a sound procurement strategy. Contacting a reputable supplier for a price quotation is the direct path to integrating this vital building block into your drug development pipeline.